Evidence map›Paper›PMID 29417372›Full record

ArticleEndocrine2018

Adipose tissue, but not skeletal muscle, sirtuin 1 expression is decreased in obesity and related to insulin sensitivity.

Magdalena Stefanowicz, Agnieszka Nikołajuk, Natalia Matulewicz, Monika Karczewska-Kupczewska

Abstract read
In one paragraph

Article in Endocrine, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed.

  1. Trial
  2. Research progress on lysine acetylation (Review).International journal of molecular medicine · 2026
    Review
  3. Article
  4. The effect of obesity and aging on NADInternational journal of obesity (2005) · 2026
    Article
  5. Review
  6. Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Review
  12. The Mystery of Exosomes in Gestational Diabetes Mellitus.Oxidative medicine and cellular longevity · 2022
    Review
  13. Review
  14. Nutrients · 2020
    Article
  15. Article
  16. Review
  17. Review
  18. Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Magdalena StefanowiczDepartment of Metabolic Diseases, Medical University of Bialystok, Bialystok, Poland.
Agnieszka NikołajukDepartment of Prophylaxis of Metabolic Diseases, Institute of Animal Reproduction and Food Research, Polish Academy of Sciences, Olsztyn, Poland.
Natalia MatulewiczDepartment of Metabolic Diseases, Medical University of Bialystok, Bialystok, Poland.
Monika Karczewska-KupczewskaDepartment of Metabolic Diseases, Medical University of Bialystok, Bialystok, Poland. monika3101@wp.pl.ORCID 0000-0003-1396-4290

Funding

Program Innovative Economy 2007-2013, partly financed by the European Union within the European Regional Development Fund UDA-POIG.01.03.01-00-128/08Seventh Framework Programme FP7-REGPOT-2010-1-264103
6 · The paper itself

Abstract

purposeSirtuin 1 may regulate glucose and lipid metabolism. We aimed to assess adipose tissue and skeletal muscle sirtuin 1 expression in relation to insulin sensitivity, the expression of proinflammatory and metabolic genes, and to study the regulation of sirtuin 1 expression by hyperinsulinemia and circulating free fatty acids elevation.

methodsWe examined 60 normal-weight, 42 overweight and 15 obese young subjects. The hyperinsulinemic-euglycemic clamp technique was applied throughout to measure insulin sensitivity. In 20 subjects, two 6 h clamps were performed, one of them with concurrent Intralipid/heparin infusion. Biopsies of subcutaneous adipose tissue and skeletal muscle were collected for the measurement of gene and protein expression.

resultsObese subjects had lower adipose sirtuin 1 in comparison with normal-weight and overweight participants. Muscle sirtuin 1 did not differ between the groups. Adipose tissue sirtuin 1 was related to insulin sensitivity, adipose tissue SLC2A4. The relationship between adipose tissue sirtuin 1 and insulin sensitivity was still present after controlling for BMI, however, it disappeared after controlling for adipose tissue SLC2A4. Muscle sirtuin 1 was not related to insulin sensitivity. Hyperisulinemia decreased adipose tissue and increased muscle sirtuin 1 expression. Intralipid/heparin infusion negated these effects.

conclusionsAdipose tissue, but not muscle, sirtuin 1 is associated with insulin sensitivity in humans, possibly because of its correlation with adipose tissue SLC2A4 expression. Insulin differentially regulates adipose tissue and skeletal muscle sirtuin 1 expression in the short-term and circulating free fatty acids elevation negates these effects, which may be associated with lipid-induced insulin resistance.

Indexed as

Insulin ResistanceAdiponectinAdipose TissueAdolescentAdultBody WeightEmulsionsFatty Acids, NonesterifiedGlucose Transporter Type 4HeparinHumansHyperinsulinismMaleMuscle, SkeletalObesityPeroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alphaAdiponectinADIPOQ protein, humanEmulsionsFatty Acids, NonesterifiedGlucose Transporter Type 4HeparinPeroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alphaPhospholipidsPPARGC1A protein, humanSIRT1 protein, humanSirtuin 1SLC2A4 protein, humanSoybean Oilsoybean oil, phospholipid emulsionAdipose tissueInsulin resistanceObesitySIRT1Skeletal muscle

Identifiers

PMID29417372
PMCPMC5893655

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.